GLMD

1.7269 -0.02 (-1.32%)

Galmed Pharmaceuticals Ltd. · NASDAQ

Performance

-9.59%

1W

-31.47%

1M

-41.86%

3M

-57.98%

6M

-45.87%

YTD

-58.77%

1Y

Profile

Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Tel Aviv, Israel.

Technical Analysis of GLMD 2025-03-14

The stock indicators suggest a bearish sentiment overall, with a Moving Average Score of 0 indicating strong downward pressure, while the Oscillators Score of 50 reflects a neutral stance, and the Technical Score of 25 reinforces the bearish outlook. This combination implies that the stock is currently facing significant challenges, with limited...
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Stock Analysis of GLMD

Created with Highcharts 11.1.03838006627270100
QualityGrowthMomentumValue4

Stock Rank

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.